Search

everythinglearnresearchcommunity

for

Search:↓

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Keratin 26 affects cashmere goat hair growth and is influenced by various treatments.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Hair loss may indicate higher heart risk and metabolic issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Garlic chive extract helped mice grow more hair by increasing a specific growth factor.

Mesenchymal Stem Cells (MSCs) are promising for multiple therapies, but more research is needed to fully understand and optimize their use.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.